Literature DB >> 32942226

Autonomic and Cardiac Repolarization Lability in Long QT Syndrome Patients.

Natalia DeMaria1, Ahmed Selmi2, Samuel Kashtan2, Xiaojuan Xia3, Matthew Wang1, Wojciech Zareba3, Jean-Philippe Couderc3, David S Auerbach4.   

Abstract

OBJECTIVE: Long QT-Syndrome (LQTS) patients are at risk of arrhythmias and seizures. We investigated whether autonomic and cardiac repolarization measures differed based on LQTS genotypes, and in LQTS patients with vs. without arrhythmias and seizures.
METHODS: We used 24-h ECGs from LQTS1 (n = 87), LQTS2 (n = 50), and LQTS genotype negative patients (LQTS(-), n = 16). Patients were stratified by LQTS genotype, and arrhythmias/seizures. Heart rate variability (HRV) and QT variability index (QTVI) measures were compared between groups during specific physiological states (minimum, middle, & maximum sympathovagal balance, LF/HF). Results were further tested using logistic regression for each ECG measure, and all HRV measures in a single multivariate model.
RESULTS: Across multiple physiological states, total autonomic (SDNN) and vagal (RMSSD, pNN50) function were lower and repolarization dynamics (QTVI) were elevated in LQTS(+), LQTS1, and LQTS2, compared to LQTS(-). Many measures remained significant in the regression models. Multivariate modeling demonstrated that SDNN, RMSSD, and pNN50 were independent markers of LQTS(+) vs. LQTS(-), and SDNN and pNN50 were markers for LQTS1 vs. LQTS(-). During sympathovagal balance (middle LF/HF), RMSSD and pNN50 distinguished LQTS1 vs. LQTS2. LQTS1 patients with arrhythmias had lower total (SDNN) and vagal (RMSSD and pNN50) autonomic function, and SDNN remained significant in the models. In contrast, ECG measures did not differ in LQTS2 patients with vs. without arrhythmias, and LQTS1 and LQTS2 with vs. without seizures.
CONCLUSION: Autonomic (HRV) and cardiac repolarization (QTVI) ECG measures differ based on LQTS genotype and history of arrhythmias in LQTS1. SDNN, RMSSD, and pNN50 were each independent markers for LQTS genotype.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Autonomic; Heart Rate Variability; Long QT Syndrome; QT Variability; Seizure

Year:  2020        PMID: 32942226      PMCID: PMC7704776          DOI: 10.1016/j.autneu.2020.102723

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  32 in total

1.  Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy.

Authors:  R D Berger; E K Kasper; K L Baughman; E Marban; H Calkins; G F Tomaselli
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

2.  Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death.

Authors:  A M Goldman; E Glasscock; J Yoo; T T Chen; T L Klassen; J L Noebels
Journal:  Sci Transl Med       Date:  2009-10-14       Impact factor: 17.956

3.  Heart rate variability in patients with congenital long QT syndrome.

Authors:  J S Perkiömäki; W Zareba; J P Couderc; A J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

4.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

5.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

Review 6.  Heart rate variability in risk stratification of cardiac patients.

Authors:  Heikki V Huikuri; Phyllis K Stein
Journal:  Prog Cardiovasc Dis       Date:  2013-08-12       Impact factor: 8.194

7.  QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Authors:  Mark C Haigney; Wojciech Zareba; Philip J Gentlesk; Robert E Goldstein; Michael Illovsky; Scott McNitt; Mark L Andrews; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

8.  In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.

Authors:  David J Gallacher; André Van de Water; Henk van der Linde; An N Hermans; Hua Rong Lu; Rob Towart; Paul G A Volders
Journal:  Cardiovasc Res       Date:  2007-06-29       Impact factor: 10.787

9.  Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome.

Authors:  David S Auerbach; Julie Jones; Brittany C Clawson; James Offord; Guy M Lenk; Ikuo Ogiwara; Kazuhiro Yamakawa; Miriam H Meisler; Jack M Parent; Lori L Isom
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

Review 10.  An Overview of Heart Rate Variability Metrics and Norms.

Authors:  Fred Shaffer; J P Ginsberg
Journal:  Front Public Health       Date:  2017-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.